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Background: The automatic tendency to attend to and focus on substance-related cues 
in the environment (attentional bias), has been found to contribute to the persistence 
of addiction. Attentional bias modification (ABM) interventions might, therefore, 
contribute to treatment outcome and the reduction of relapse rates. Based on some 
promising research findings, we designed a study to test the clinical relevance of ABM 
as an add-on component of regular intervention for alcohol and cannabis patients.
Design/Methods: The current protocol describes a study which will investigate the 
effectiveness and cost-effectiveness of a newly developed home-delivered, multi-
session, internet-based ABM intervention as an add-on to treatment as usual (TAU). 
TAU consists of cognitive behavioural therapy-based treatment according to the Dutch 
guidelines for the treatment of addiction. Participants (N = 213) will be outpatients from 
specialized addiction care institutions diagnosed with alcohol or cannabis dependency 
who will be randomly assigned to one of three conditions: TAU + ABM; TAU + placebo 
condition; TAU-only. Primary outcome measures are substance use, craving, and rates 
of relapse. Changes in attentional bias will be measured to investigate whether changes 
in primary outcome measures can be attributed to the modification of attentional bias. 
Indices of cost-effectiveness and secondary physical and psychological complaints 
(depression, anxiety, and stress) are assessed as secondary outcome measures.
Conclusions: This randomized control trial will be the first to investigate whether 
a home-delivered, multi-session ABM intervention is (cost-) effective in reducing 
relapse rates in alcohol and cannabis dependency as an add-on to TAU, compared with 
an active and a waiting list control group. If proven effective, this ABM intervention 
could be easily implemented as a home-delivered component of current TAU. 
Keywords: Addiction, Attentional bias modification, eHealth
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INTRODUCTION
Alcohol and drug use disorders are well known for their persistent character. People 
diagnosed with substance use disorders are usually well aware of the undesirable 
consequences of their substance use and, therefore, often desire to quit. However, in 
spite of their motivation to stop, they frequently report an inability to voluntarily control 
their alcohol or drug use. This loss of control is associated with high rates of relapse, 
which have been found to be 40-50% one year after successful treatment, rising to 
70% three years later (National Institute on Drug Abuse, 2012; Cutler & Fishbain, 2005). 
These numbers indicate that current interventions might not successfully address 
all relevant aspects of addiction. Therefore, (cost-) effective methods of improving 
existing interventions need to be developed, in order to lower rates of relapse and 
thereby increase patients’ quality of life.   
Most current interventions in addiction care, such as cognitive behavioural therapy 
(CBT), focus on conscious decision-making and behavioural control, such as learning 
how to recognize ‘risky’ situations, and to unravel and change possible ‘wrong beliefs’ 
about the alcohol or drug use. This restricted focus of current interventions on conscious 
processes might be a possible reason for their limited success rates. Accordingly, 
current dual process models of addiction emphasize that next to the conscious cognitive 
processes also more automatic processes, such as attentional bias (AB), play a crucial 
role in the development and persistence of addiction (Gladwin & Figner, 2015; Wiers 
et al., 2007). AB in substance dependency can be defined as an automatic tendency 
to focus attention on substance-related cues in the environment (Field & Cox, 2008; 
Wiers, Field, & Stacy, 2014), such as alcohol advertisement or a used joint on the street. 
AB for substance-related cues has repeatedly been found in different substance use 
disorders, such as alcohol, tobacco, and opioids dependency (Lubman, Peters, Mogg, 
Bradley, & Deakin, 2000; Mogg, Bradley, Field, & de Houwer, 2003; Roy-Charland 
et al., 2017; for a critical review on the role of AB in addiction see Field et al., 2016). 
Heightened attention to substance-related cues can involve two processes. The first 
process is attentional engagement bias, reflecting increased direction of attention 
towards substance-related cues. The second process is attentional disengagement 
bias, reflecting increased subsequent difficulty disengaging attention from substance-
related cues. In addiction, both types of AB appear to operate. Patients diagnosed with 
substance use disorder are likely to become quickly aware of substance-related cues 
in their environment (van Hemel-Ruiter, Wiers, Brook, & de Jong, 2015), plausibly 
indicating that attention is spontaneously drawn towards these cues. Furthermore, 
heavy users seem to focus their attention longer on substance-related information than 
do social users (Field, Mogg, Zetteler, & Bradley, 2004), which suggests that heavy users 
experience difficulty disengaging their attention away from substance-related cues.
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Both biases in attention will increase awareness of substance-related cues, which might 
be especially problematic for people who would like to stop or to reduce their intake 
of alcohol or drugs (Cox, Hogan, Kristian, & Race, 2002). That is, patients diagnosed 
with substance use disorders seem to be surrounded by relatively many temptations, 
which makes resisting even more challenging. Recent research supports the idea that 
AB towards alcohol and drug cues is related to the intensity and persistence of addictive 
behaviours. First, AB has been found to increase in strength during the course of more 
frequent and increased use of the addictive substance (Fadardi & Cox, 2006). In other 
words, the strength of AB favouring substance-related cues is related to the severity of 
addiction. This may reflect a self-reinforcing bias-use-bias cycle, in which increased 
substance use induces increased AB which in turn increases substance use and so 
on. This may render it increasingly difficult to quit the use of addictive substances. 
Second, higher levels of subjective craving have been found to be related to stronger 
AB favouring substance-related cues (Field, Munafó, & Franken, 2009). Such increased 
attention to substance-related information may increase the desire to use and, as a 
result, interfere with the deliberate intention limiting or stopping the intake of alcohol 
or drugs. Third, greater AB to substance-related cues prior to treatment has been 
shown to be related to poorer treatment outcome (Carpenter, Schreiber, Church, & 
McDowell, 2006), indicating that people who display greater AB to substance-related 
cues benefit less from current interventions than people who exhibit little or no 
such AB. Finally, some studies have found that strong AB to substance-related cues 
increases the risk of relapse after successful treatment (Schoenmakers et al., 2010). 
Importantly, recent studies have found that this AB is largely unaffected by current 
CBT-based interventions (van Hemel-Ruiter et al., 2015; Thus et al., 2009), suggesting 
that an intervention aimed at directly reducing AB to substance-related cues might 
add to the effects of traditional CBT. 
In line with this, a new type of interventions has been developed with the specific 
aim of modifying biased information processes, collectively called cognitive bias 
modification (CBM) interventions. The subset of CBM interventions specifically targeting 
AB are referred to as attentional bias modification (ABM) interventions. Both in the 
context of experimental research and clinical trials, it has been shown that AB can be 
effectively altered using computerized procedures (Schoenmakers et al., 2010; Field 
& Eastwood, 2005; Schoenmakers, Wiers, Jones, Bruce, & Jansen, 2007). However, in 
order to achieve clinically meaningful effects it is important that reduced AB results in 
changes of substance use-related symptoms. Of course, if an ABM intervention does 
not modify AB, then no changes in symptoms or behaviour can be expected (Clarke, 
Notebaert, & MacLeod, 2014; MacLeod & Grafton, 2016), and ABM interventions are 
unlikely to be effective when AB is not present prior to the intervention (Begh et al., 
2015; Mayer et al., 2016; McHugh, Murray, Hearon, Calkins, & Otto, 2010). However, if 
an ABM intervention does result in the reduction of pre-existing AB, then it becomes 
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plausible that there also will be corresponding reduction in symptoms that are in 
part caused or maintained by this AB, and such changes in clinical symptoms can be 
evaluated. It has been observed that in recent research the successful modification 
of AB to substance-related cues has often not been transferred into these desired 
behavioural changes, such as reduced alcohol or drug intake or increased time until 
relapse (Schoenmakers et al., 2007; Lee & Lee, 2015). Therefore, it seems important to 
consider the factors that may moderate whether the modification of such AB delivers 
these clinically meaningful benefits. 
One important factor may be motivation to change. In most of the experimental 
studies in which AB to substance-related cues has been modified successfully, without 
corresponding change in problematic substance use behaviour, participants have 
been non-clinical volunteers without apparent motivation to change their substance 
use (Field & Eastwood, 2005; Schoenmakers et al., 2007; Kerst & Waters, 2014). To 
test the capacity of ABM interventions to attenuate addiction-related symptoms in 
clinical cohorts, it is necessary to deliver ABM interventions to samples of treatment-
seeking participants; patients who are motivated to change their problem behaviour. 
In line with this, recent research in an outpatients clinical sample found that adding 
an ABM intervention to regular treatment not only led to greater reduction in AB to 
substance-related cues, but also to longer times until relapse, when compared with 
a placebo control condition (Schoenmakers et al., 2010). Such findings are consistent 
with the idea that, when patients are motivated to change, the direct modification of 
AB to substance-related cues can add to the efficacy of conventional interventions. 
Another factor that may moderate the efficacy of ABM interventions is the context 
in which the intervention is delivered. Within the field of social anxiety research, 
interventions designed to reduce AB to social threat cues have been shown to yield 
beneficial effects on social anxiety when delivered in the laboratory or clinic (Amir 
et al., 2009; Schmidt, Richey, Buckner, & Timpano, 2009), but often do not deliver 
such benefits when administered as home-delivered interventions (Carlbring et al., 
2012). Typically, in the home environment, these interventions fail to alter attention 
to social threat cues. A possible explanation might be that people diagnosed with social 
anxiety disorder experience their home environment as a safe place, and do not display 
attentional vigilance for threat cues or experience anxiety in their home setting. This 
lack of anxiety and the absence of AB prior to the intervention might interfere with 
its efficacy (de Jong, 2016). In line, the theory of emotional processing suggests that 
fear-relevant information needs to be activated in order to change it successfully (Foa 
& Kozak, 1986).  In contrast, in substance use disorders the experience of craving can be 
expected to be experienced most strongly in the home environment, as craving is likely 
to be strongest within the environment in which people typically tend to use (Stevenson 
et al., 2017). As the laboratory or clinic are novel environments, these are not likely to 
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induce craving and thus ABM interventions might be less effective when delivered in 
these types of substance-use irrelevant environments. Thus, ABM interventions for 
substance dependency might be even more effective when delivered at home and when 
the experience of craving is high. However, in apparent conflict with this, a study in 
which an ABM intervention was delivered via the internet failed to find convincing 
support for its efficacy (Wiers et al., 2015). Although participants in the ABM group 
showed a reduction in the consumed glasses of alcohol a day, this effect could not be 
attributed to the intervention, because the same effect was found in the placebo control 
group. Importantly, this study delivered a web-based ABM intervention in the absence 
of any other (motivational) intervention, and participants did not intent to stop or to 
reduce their alcohol use. In order to clarify the effectiveness of home-delivered ABM 
interventions in substance dependency more research accounting for all important 
factors is needed.
A potentially important limitation of previous studies, which may have constrained 
their therapeutic impact, concerns the simplicity of current attentional training tasks 
that have been employed with the aim of altering real world AB. Typically, these tasks 
have presented only two static stimuli, one of which is related to the target category of 
information, such as alcohol, and participants have been required to discriminate the 
identity of a small “probe” that appears either in the locus of this stimulus or in the 
locus of the other neutral stimulus. By presenting these probes distally from the target 
stimulus, it is hoped that participants will come to attend away from this category of 
information (MacLeod, Rutherford, Campbell, Ebsworthy, & Holker, 2002). This simple 
task, displaying only two static stimuli, does not challenge the attentional system, and 
clearly lacks the dynamic complexity of real world settings, which may limit transfer 
of the resulting training effects to real-life situations (Hertel & Mathews, 2011). Hence, 
it would be desirable to develop more complex and dynamic ABM interventions in 
order to train change in attentional vigilance to substance-related information that 
is most likely to transfer into real-world settings, and so drive therapeutic changes 
in substance use-related behaviour and symptoms. 
Another important potential consideration is the number of training sessions that 
should be included in an ABM intervention. Laboratory studies have shown that a 
single session of ABM intervention can modify AB transiently, but studies using this 
approach to alter attention to substance-related cues have not found generalization 
of such effects to new stimuli that were not employed in the training procedure 
nor changes in substance use-related symptoms (Attwood, O’Sullivan, Leonards, 
Mackintosh, & Munafó, 2008; Field & Eastwood, 2005; Schoenmakers et al., 2007). This 
suggests that multiple sessions of ABM intervention are likely to be necessary for the 
modification of AB to generalize to novel stimuli, and translate into relevant changes 
in substance use-related symptoms. In line with this, preliminary evidence shows that 
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the modification of AB to substance-related cues through multiple sessions can result 
in changes of substance use-related behaviour (Schoenmakers et al., 2010). Given the 
need to deliver multiple training sessions to produce clinically meaningful change in 
symptoms, it is necessary to ensure that participant motivation is sustained. This, it 
may be advisable to add motivational components to the ABM intervention, either face 
to face or online. Such components, which may include motivational interviewing, could 
be designed to increase motivation to change substance use (van Deursen, Salemink, 
Smit, Kramer & Wiers, 2013) or motivation to finish the ABM intervention in particular 
(Boffo, Pronk, Wiers, & Mannarini, 2015). Another way to increase motivation to remain 
engaged in a multi-session ABM intervention would be to make the training itself more 
appealing, for example via gamification of the intervention (Boendermaker, Prins, & 
Wiers, 2015; Dennis & O’Toole, 2014). Of course, while such gamification is likely to 
increase motivation to perform the training, it may not enhance motivation to change 
addictive behaviour (Boendermaker et al., 2015). Therefore, it will be important to 
sustain regular treatment, including motivational components.  
Based on these considerations, the current study will investigate the effects of a 
gamified, home-delivered, and internet-based multi-session ABM intervention as 
an add-on to regular face-to-face protocolled TAU. This combined treatment may 
strengthen the motivation to change by sustaining treatment as usual (TAU) on the 
one hand, while also directly reducing AB favouring substance-related cues (ABM 
intervention) on the other hand, leading to improved treatment outcome and decreased 
rates of relapse.
TRIAL OBJECTIVE AND HYPOTHESIS
The current study will investigate the effectiveness of a newly developed internet-based 
ABM training as an add-on intervention to treatment as usual (TAU; consisting of 
protocolled CBT-based interventions), in alcohol and cannabis dependent outpatients. 
More specifically, the study will evaluate whether this new ABM training enhances 
treatment outcomes, and may be a cost-effective component that should be added 
to treatment in addiction care. The focus of the study is to examine the additional 
effects of ABM training on changes in substance use, craving, and relapse rates. 
Measurements of AB will serve as a manipulation check for the efficacy of the current 
training to successfully modify AB. This is important because only if the current ABM 
intervention is effective in modifying patients’ AB it can be expected to have an impact 
on their substance use. 
Based on this objective, we will test the hypothesis that patients who receive ABM 
intervention, compared to controls, will show less substance use, less craving, and 
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lower relapse rates at post-measurement and 6 and 12 months after treatment. In 
addition, we will test if patients who received ABM intervention will show increased 
health and reduced physical and psychological complaints. Furthermore, we predict 
that these patients will show a reduction in health care usage 6 and 12 months after 
the intervention. Moreover, we predict that the effects on the individual and societal 
level will cause a decrease in societal costs that outweighs the additional costs of ABM 
intervention. Finally, we hypothesize that participants who show a stronger AB and 




The present study is a multicentre randomized controlled two-armed, parallel-designed 
trial with one treatment arm (ABM intervention) and a control arm, which will be 
divided into a placebo condition and a TAU-only condition (see Figure 1). The inclusion 
of these two control conditions enables (1) the investigation of the effect of TAU + ABM 
intervention, related to TAU-only, and (2) the control for a possible placebo effect, 
by comparing the ABM condition with the placebo condition. The design of the study 
enables that ABM intervention, as well as the placebo condition, can be provided parallel 
to treatment as usual (TAU). Recruitment will take place in four addiction care centres 
in the Netherlands (Iriszorg, Novadic-Kentron, Tactus Verslavingszorg and Verslavingszorg 
Noord Nederland). There are two treatment intensities in the Dutch mental health care 
system. All participants who will be included in this study will receive the lower dose 
treatment, in which TAU consists of 350 to 750 minutes of protocolled CBT-based 
intervention in a specialized addiction care institution, including a 30% range of 
possible additional interventions, such as medication. Whether therapists make use 
of such additional intervention components depends on the severity of addiction and 
possible related problems of the patients. Patients who are ascribed to this intensity of 
treatment are expected to live relatively independent and to report less comorbidity. 
The additional effects of the ABM intervention will be tested directly after the end of 
TAU, which is also the end of the training, and 6 and 12 months later. For an overview 
of the planned timeline of the study, see Figure 2. 
This study was approved by the ethical committee of the University Medical Centre of 
Groningen (UMCG; METc 2016/026) and is registered at the Netherlands Trial Register 
(NTR5497). It is partially funded by ZonMw (The Netherlands Organisation for Health 
Research and Development; 80-84300-98-61035), and co-financed by Verslavingszorg 
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Noord Nederland. Modifications to the study protocol will be communicated with the 
ethical committee as well as with ZonMw. This trial protocol is written in adherence 
with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 
guidelines.
Figure 1. Participant flowchart.
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Figure 2. Expected timeline of completion and reporting of results.
PARTICIPANTS AND PROCEDURE
Participants will be treatment-seeking adult patients diagnosed with alcohol use 
disorder (AUD) or cannabis use disorder (CUD) with an indication for TAU in addiction 
care as described above. Recruitment will take place at the four addiction care centres. 
The therapists will inform all their patients during the intake or the fi rst session of 
TAU about the possibility of participating in a study. Interested patients will receive 
a folder, containing a leafl et from the Dutch government about scientifi c research in 
general, a patient information letter with specifi c information about the current study, 
an informed consent form with envelope, and a small card with contact information of 
the studies’ helpdesk. If patients give permission to their therapist, he/she will forward 
the patients’ contact information to a researcher, who will call them a few days later 
in order to screen for eligibility and to give a brief oral explanation about the study 
rationale and the norms of data processing. Thus, recruitment will be done by the 
researchers, while the therapists are responsible for providing the fi rst information 
to their patients. Patients will be included if they (a) are 18 years or older, (b) have a 
main diagnosis of AUD or CUD, and (c) have an indication for TAU in addiction care as 
described above. A contra-indication for participation is (a) a problem with compulsive 
gaming, gambling disorder, or internet addiction as measured with a short version of 
the C-VAT 2.0 (van Rooij, Schoenmakers, & van de Mheen, 2014) and/or (b) the absence 
of a personal computer or laptop and/or no access to internet. Eligible patients who 
decide to participate will be asked to sign the informed consent form and to send it to 
the researcher. After receiving the signed informed consent form, they will be assigned 
to the online registration and monitoring tool of the study. The signed informed 
consent form needs to arrive at the researchers’ offi  ce within the period of the fi rst 
three sessions of TAU. Otherwise the potential participant is excluded from the study, 
as early eff ects of TAU could distort pre-measures too much. 
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After assignment to the system, all participants will be invited by e-mail to complete 
the baseline assessment. Participants who are assigned to the TAU-only condition will 
thereafter receive TAU. Participants who are assigned to one of the trainings (active or 
placebo) will thereafter read the training instructions. Furthermore, they can watch an 
animated video in which the training is explained. Hereafter a short 5-minute practice 
session of the training follows. One day after completing the baseline assessment 
and the practice session of the training, participants in one of the training conditions 
will receive an invitation for the first training session by e-mail. The following three 
weeks, participants will be asked to train on a daily basis. Thereafter, the number of 
training sessions per week will decline. Participants will train three times a week for 
another three weeks and finally once a week until the end of TAU. Thus, the actual 
number of training sessions is dependent on the duration of TAU. The lower doses 
treatment in the Dutch addiction care usually takes 3 to 6 months, depending on the 
severity and the progress of the patient. During the whole training period a researcher 
will monitor the process of the patients and whether they train regularly. After three 
training sessions are missed, patients will receive an automatic reminder by e-mail. 
If this does not result in the continuation of the training the researcher will contact 
the patient via the preferred way (phone, e-mail, text message or app) in order to ask 
whether there are any problems or doubts about the participation in the study. 
An important part of the study is the involvement of the therapists. In order to improve 
adherence, the researchers will train the therapists before the inclusion of participants 
starts. The training will consist of the following parts (1) general background knowledge 
about AB and ABM, (2) design and important parts of the study, and (3) the role of 
the therapists. During the training all therapists will receive a protocol in which all 
important aspects are described. In the first session of TAU after patients are assigned 
to the study, therapists will identify the time of the day patients’ craving is strongest 
and will instruct the patient to complete the ABM task at this particular time of the 
day. Furthermore, during each following treatment session of TAU, the therapist 
will ask the participant whether he/she trains on a regular basis, and will engage in 
motivational counselling if this is not the case.
During the last week of TAU in addiction care, participants in the training conditions 
will receive the last training invitation by e-mail. After completion, they will be invited 
for the post-assessment. Participants in the TAU-only condition will also receive the 
invitation for the post-assessment in their last week of TAU. Finally, 6 and 12 months 
after the end of TAU, all participants will receive an invitation for the follow-up 
measurements by e-mail. In case a participant does not respond to these invitations, the 
researcher will remind the patient via the preferred way (phone, e-mail, text message 
or app). Throughout the length of the whole project, a sounding board group will meet 
four times to monitor the process of the study. The group will include a researcher, 
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a therapist, and a member of the client council of each addiction care centre, and an 
implementation professional. 
INTERVENTIONS 
ATTENTIONAL BIAS MODIFICATION TRAINING 
In this study, the approach adopted to train patients to reduce attention to substance-
related cues will be a variant of the recently developed bouncing image training task 
(BITT), based on the follow the face task that was originally designed by Colin MacLeod 
and colleagues (Notebeart et al., 2018). This computerized task was developed to promote 
attentional disengagement from substance-relevant cues and attentional engagement 
with neutral, substance-irrelevant cues. The task requires participants to engage 
attention with substance-irrelevant cues while ignoring substance-relevant cues, and 
to disengage attention from the currently attended locus whenever substance-relevant 
cues appear there. 
In the current BITT, 8 squares move around a computer screen (1024 x 600 pixels). 
Seven of these contain substance-relevant images, whereas one contains a substance-
irrelevant image. Participants are instructed to attentionally follow the moving 
substance-irrelevant image and keeping their mouse cursor in the locus of this image. 
The challenging part of the task is that the images in all eight squares change at frequent 
unpredictable time intervals. Most of the time, the substance-irrelevant image will 
change into another substance-irrelevant image (e.g., from tea to water or from pen to 
post-it), while all the substance-relevant images change to other substance-relevant 
images, meaning that participants must maintain attention on and track the same 
image. However, on random occasions the substance-irrelevant image will change into 
a substance-relevant image, and one of the substance-relevant images will change to 
a substance-irrelevant image. At this point, participants must immediately disengage 
their attention from the square they were previously tracking, which now contains 
a substance-relevant image, and switch their attention to engage as fast as possible 
with the square that now contains the substance-irrelevant image. As soon as the 
participants locate the mouse cursor on the substance-irrelevant image, this image 
becomes green-filtered for 500 ms, so that participants know they are tracking the 
‘right’ image. Each training session is divided into four blocks of 2.5 minutes. 
To enhance the motivation of participants to train regularly and to make the training 
more appealing, some game-like features were added to the original version of the BITT. 
First, the training consists of 12 different levels, gradually increasing in difficulty. The 
construction of the levels is based on three factors: Moving speed of squares, interval 
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of switching of images within squares, and interval of switching of images between 
squares. In order to adapt the difficulty of the levels to the abilities of the current 
population, the speed of the levels was tested in a small group of patients diagnosed 
with AUD and CUD in one of the addiction care centres during the test phase. In the 
beginning of the training phase, all participants start with level one and thereafter can 
unlock more challenging levels by reaching a certain amount of points. This cut-off 
score is 80, which equals a tracking time of 2 minutes per block. The high-scores of 
each level are stored, so that participants can challenge themselves by reaching higher 
scores during the next block or training session. Participants are instructed to choose 
a level that is challenging, but not too difficult and thereby frustrating. The number 
of trials depends on the level at which participants are training. Second, participants 
receive feedback about their performance in the form of points, calculated for each 
block. The more accurately participants track the substance-irrelevant image with the 
mouse cursor, the higher their score. While training, the participants’ accruing score 
is indicated by the length of a green bar shown on the screen. A mark on the bar gives 
them feedback about whether they already unlocked the next level. Next to the bar, 
they can also see the remaining time per block. There are two versions of the BITT: 
One contains stimuli that are relevant for patients diagnosed with AUD, whereas the 
other contains stimuli relevant for CUD patients. 
To test the effect of the BITT on participants’ ability to engage attention with substance-
irrelevant cues while ignoring substance-relevant cues, we will test the increase in 
tracking time of the substance-irrelevant cue over the course of treatment. To test the 
effect of the BITT on participants’ ability to disengage attention from the currently 
attended locus whenever substance-relevant cues appear there, we will examine 
the change in switching time over the course of treatment. To measure transfer of 
the improvement in BITT performance in terms of enhanced orientation towards 
substance-irrelevant cues and enhanced ability to disengage from substance cues, 
we also included a visual search task to measure AB (see below). 
PLACEBO CONDITION
The placebo condition is designed to be similar to the active BITT, and the stimuli, the 
design/layout, the temporal parameters, and the construction of levels are all equal to 
the active intervention. However, in the control condition the task is not configured 
to reduce attention to substance-related cues. 
In contrast to the active intervention, the placebo condition consists of four substance-
relevant and four substance-irrelevant images moving on the screen. Participants are 
instructed to equally pay attention to all eight images until one of the squares turns 
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green. They are asked to click on this green-filtered image as quickly as possible. 
The green filter appears in an unpredictable location at unpredictable time intervals. 
Throughout the task, the squares containing substance-relevant and substance-
irrelevant images turn green equally often (50:50 ratio).  
TASK STIMULI
The stimuli of the alcohol and cannabis version of the BITT and the placebo condition 
consist of the same two sets of 64 images (500x500 pixels). Whereas the first set of 64 
images is used during most of the training sessions, the second set is only used for the 
last training session in order to measure generalization to new (untrained) stimuli. The 
32 substance-relevant images of the alcohol version show different alcohol beverages, 
such as beer, wine, or whiskey. The substance-irrelevant category consists of 32 
non-alcoholic drink images (e.g., soda, tea, or coffee). The images of both categories 
show a bottle, a bottle with an empty glass, or a bottle with a filled glass. The cannabis 
version is constructed of 32 substance-relevant images showing objects related to 
cannabis use (e.g., weed, joint, or rolling paper) and 32 substance-irrelevant pictures 
containing office products (e.g., pen, post-it, or paperclips). All used pictures were 
used in earlier studies (van Hemel-Ruiter et al., 2015; Pronk, van Deursen, Beraha, 
Larsen, & Wiers, 2015). For each block of a training session, 8 substance-relevant and 
8 substance-irrelevant images are randomly drawn from the 64 available images. 
For the next block, 16 other pictures will be used. Thus, throughout each training 
session all 64 images are presented to the participant. As images switch within an 
unpredictable time interval and dependent on the actual level, the number of times 
an image is presented within one block is not fixed. Yet, as participants reach higher 
levels and the speed of switching increases, each image is presented more often within 
one block. The background of all images is white and they are matched by colour, type 
of bottle/package, and size of bottle/package. Furthermore, all stimuli are passive, 
which means that no persons are shown in the pictures. For an example of training 
stimuli, see Figure 3.
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Figure 3. Example of training stimuli of the alcohol and cannabis version.
BASELINE, POST MEASUREMENT AND FOLLOW-UPS 
ATTENTIONAL BIAS ASSESSMENT 
AB to substance-related cues is measured using the Odd-One-Out task approach
(originally introduced by Hansen & Hansen, 1988, and later modifi ed by other 
researchers). In this task, participants have to identify whether 20 pictures (500x500 
pixel), presented in a 4 x 5 matrix, all belong to the same single category or whether 
one picture belongs to a category distinct from all the others. Dependent on the 
diagnosis of the participant, all pictures belong to one of the following three categories: 
alcoholic drinks, non-alcoholic drinks, and fl owerpots or cannabis-related objects, 
neutral daily life devices, and fl owers, respectively for AUD and CUD. Due to these three 
categories, there are three conditions in which no odd-one-out picture can be found 
in the matrix (e.g., all 20 pictures show alcoholic drinks). Accordingly, there are six 
possible combinations in which an odd-one-out picture is present (e.g., 19 pictures 
contain cannabis-related objects and one picture shows a fl ower). For an overview of 
all nine conditions per diagnoses see Table 1. The possible combinations of conditions 
are balanced and the order of trials is random. The task is divided into three blocks of 
24 trials each, and within each block, there will be 18 trials with an odd one out picture 
and 6 trials without an odd-one-out picture. The duration of each trial is dependent on 
the reaction time of the participant, but last 10 seconds at most. Responses are given 
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by the answer buttons on the keyboard; 1 for ‘yes, there is an odd-one-out’ and 0 for 
‘no, there is no odd-one-out’. Between trials, participants are instructed to focus their 
attention on a red fixation cross in the middle of the screen, which is presented for 
500 ms. For both versions (alcohol and cannabis), we will use a total of 90 pictures, 
meaning that there are 30 different pictures per category. Per trial, the 20 pictures 
that are presented in the matrix are randomly drawn from the available pictures. The 
pictures of the alcoholic and non-alcoholic drinks (Pronk et al., 2015) and the pictures 
of cannabis-related objects and neutral daily life devices (Cousijn, Goudriaan, & Wiers, 
2011; Cousijn et al., 2011; Cousijn et al., 2013; Cousijn, van Benthem, van der Schee, & 
Spijkerman, 2015) were used in earlier studies and permission was asked. The pictures 
of flowerpots and flowers were taken for the purpose of the current study.
AB scores will be calculated by subtracting the mean reaction time of trials with one 
neutral picture among 19 substance-relevant pictures (condition 4 and 5; see Table 
1) from the mean reaction time of trials with one substance-relevant picture among 
19 neutral pictures (condition 6 and 7). A positive score indicates that participants are 
faster in finding substance-relevant information within neutral information, than 
finding a neutral stimulus in an array of substance-relevant pictures, and thus reflect 
an AB for substance-related cues.
Table 1 
Type and amount of trials in the Odd-One-Out task, separated for AUD and CUD 
Condition Type of trials AUD Type of trials CUD Trials per block
1 20 alcohol images 20 cannabis-related images 2
2 20 soft drink images 20 neutral images other than flowers 2
3 20 flowerpot images 20 flower images 2
4 19 alcohol 1 soft drink 19 cannabis-related 1 neutral 3
5 19 alcohol 1 flowerpot 19 cannabis-related 1 flower 3
6 19 soft drink 1 alcohol 19 neutral 1 cannabis-related 3
7 19 flowerpot 1 alcohol 19 flower 1 cannabis-related 3
8 19 soft drink 1 flowerpot 19 neutral 1 flower 3
9 19 flowerpot 1 soft drink 19 flower 1 neutral 3
Note. AUD = alcohol use disorder; CUD = cannabis use disorder
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QUESTIONNAIRES
Participants’ general health state is assessed by means of the EuroQol-5D-3L 
questionnaire (Rabin & de Charro, 2001). Health care-related costs are evaluated with 
the Treatment Inventory of Costs in Psychiatric Patients questionnaire (Bouwmans 
et al., 2013). The Measurements in Addiction for Triage and Evaluation questionnaire 
(Schippers & Broekman, 2014) is a standard instrument in the Dutch addiction care 
and will be completed during the intake and at the end of the treatment through the 
therapists. During the 6 and 12 months follow-up measurements, the same questions 
will be asked online. For this study, the following parts of the MATE will be evaluated: 
substance use, the Obsessive-Compulsive Drinking Scale (OCDS5), and the Depression 
Anxiety Stress Scale (DASS).
OTHER MEASUREMENTS 
During the baseline assessment, sociodemographic information will be collected, 
such as gender, relationship, level of education, and work. Furthermore, details of the 
patients’ own clinical history of addiction as well as of their family will be asked. Next, 
participants who are assigned to one of the training conditions will be asked about their 
expectations of the intervention. Before and after each training session, participants 
will rate their intensity of craving on a visual analogue scale (VAS), varying from 0 
(no craving at all) to 100 (extreme craving). With this, possible direct effects of the 
intervention on subjective craving can be examined. Furthermore, at the end of the 
baseline assessment, all participants are asked to fill in a short questionnaire about 
their computer/laptop use in their private life. This information might be helpful when 
investigating for whom this ABM intervention was effective. Last, after the first week 
of training and during the post-assessment, participants, who are assigned to one of 
the training conditions, will be asked to fill in an evaluation questionnaire, in which 
they can give their opinion about the intervention and are asked to indicate whether 
the intervention helped them. Information derived from these questionnaires can be 
used as indications for possible next steps towards implementation. For an overview 
of all questionnaires and tasks per time point, see Table 2. 




Overview of measurement instruments per time point
Purpose Measures Baseline Post-assessment Follow-up
Attentional bias 
assessment
Odd-One-Out task X X X
Baseline measures Demographics
History of addiction

































Note. *only to be filled in by participants in one of the training conditions
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PRIMARY AND SECONDARY OUTCOME MEASURES
The effectiveness of the ABM intervention will be examined by changes in substance 
use (i.e. quantity of use in the past 30 days), craving, and relapse rates. Measurements 
of AB will serve as a manipulation check for the effects of ABM intervention.1 Secondary 
outcome measures are cost-effectiveness2, and secondary physical and psychological 
complaints (depression, anxiety, and stress). The evaluation forms of the patients and 
therapists will be assessed as well. 
SAMPLE SIZE
To find a difference between groups of medium effect size with a power of 0.8 at an 
alpha of 0.05, both the treatment and the control arm need to include 64 patients, as 
calculated with G*power 3.1.5. Dropout rates in regular addiction treatment are known to 
be approximately 20%. Given the 6 and 12 months follow-up measurements a dropout 
rate of 40% was calculated. Therefore, a total amount of 213 patients will be recruited.
WITHDRAWAL
All participants can withdraw from the study at any time. However, they are asked 
whether they are willing to complete the measurements. Thus, even if participants 
stop the training (ABM intervention), they are still invited to participate in the post-
assessment and follow-up assessments.   
RANDOMIZATION
Participants who meet the inclusion criteria will be automatically assigned to one of 
the three conditions with the following likelihood (1) 50% TAU + ABM, (2) 25% TAU + 
placebo condition and (3) 25% TAU-only. Furthermore, the registration and monitoring 
system stratifies for gender, age group (18-30, 30-50, 50+), type of addiction, and 
institution. Therefore, participants are assigned to one of the three conditions to which 
the fewest participants of their gender, age group, and type of addiction are assigned 
accounting for the institution of the participants. When proven effective, participants 
in the control conditions (TAU + placebo condition and TAU-only) will be offered the 
ABM intervention after the end of the study (approx. end 2018). 




Since all assessments take place online, thus in the absence of the researchers, the 
outcome data are blinded. However, one researcher will be aware of the condition of 
the participants in order to support them appropriately when technical or personal 
problems appear. It is unlikely that this will entail problems of bias, as the researcher 
is not involved in any measurement and the motivational part of the study lies in the 
responsibility of the therapists. The therapists and participants will be blinded for the 
two training conditions. Therefore, the ABM intervention and the placebo condition 
were designed such that the use of the same task stimuli would be possible, making 
both conditions look very similar. Furthermore, it is unlikely that participants will 
tell their therapists much about the content of the training, but more about whether 
they train regularly or whether they like or dislike the training. This will help to keep 
the therapists blinded. Furthermore, the therapists will be instructed not to do any 
‘research’ about what might be the ´real´ intervention. Participants will be asked to 
indicate their expectation about their condition in the post-assessment.  
DATA ANALYSES
CLINICAL ANALYSIS
First, changes in AB, as measured with the Odd-One-Out task, will be examined by 
using a 4 (within subjects: pre, post, FU1, FU2) x 2 (between subjects: TAU + ABM 
versus control conditions) repeated measure ANOVA, with AB as dependent variable. 
To assess the validity of the main hypothesis, a 4 (within subjects: pre, post, FU1, 
FU2) x 2 (between subjects: TAU + ABM versus control conditions) repeated measure 
ANOVA will be conducted to examine the effects of the ABM intervention on substance 
use and craving, as measured with the MATE. In order to evaluate the effects of ABM 
intervention on rates of relapse, a Cox regression analysis will be conducted to model 
the time until relapse occur.
Further, changes in secondary physical and psychological complaints (depression, 
anxiety and stress) will be tested by a 4 (within subjects: pre, post, FU1, FU2) x 2 
(between subjects: TAU + ABM versus control conditions) repeated measure ANOVA, 
based on the MATE. Missing data will be handled with multiple imputation.
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ECONOMIC EVALUATION
If the ABM intervention was shown to be effective, the economic evaluation will be 
performed from a societal perspective, which means that all relevant costs will be taken 
into account, regardless of who pays for them. Health-care costs, such as contacts 
with health care professionals, and costs of lost productivity will be calculated by 
multiplying the volumes of health-care with standard unit prices derived from the 
Dutch Manual for cost research (Zorginstituut Nederland, 2015).
The time horizon of the economic evaluation will be 12 months and will compare the 
ABM intervention to TAU-only.  Cost-effectiveness and cost utility will be assessed by 
relating the incremental costs of the two treatments to the incremental outcomes. The 
primary outcome measure in the cost effectiveness analysis will be substance use and 
relapse rates, as measured with the MATE and additional questions regarding relapse. 
In addition, a cost utility analysis will be performed with quality-adjusted life years 
(QALYs) as primary outcome, based on the EQ-5D-3L defined utilities. No discounting 
of costs and effects will be conducted, since the time horizon does not exceed 1 year. 
Uncertainty surrounding the cost-effectiveness and cost utility ratios will be assessed 
using bootstrap analysis. In addition, cost-effectiveness acceptability curves will be used 
to inform decision-makers on the probability that ABM intervention is cost effective.
DATA MANAGEMENT AND SAFETY MONITORING
The proceedings of data security and storage are established in a data management 
plan, which was written according to the guidelines of the funding agent ZonMw. For 
detailed information about this plan please contact the first author. All serious adverse 
events will be reported to the ethical committee as well as to the funder of the study 
and will be discussed in case action is necessary. 




Relapse rates in alcohol and drug use disorders remain high even after conventional 
treatment has been initially successful. This emphasizes the need for more (cost-) 
effective therapies in addiction care. In this trial protocol, we describe the design of a 
randomized control trial to investigate the effectiveness of an internet-based multi-
session ABM training as an add-on intervention to regular face-to-face treatment 
(TAU) in alcohol and cannabis dependent outpatients. To the best of our knowledge, 
this study will be the first RCT to test the effects of an internet-based attentional 
bias modification intervention, integrated with a complete cognitive behavioural 
therapy-based treatment, on treatment outcome and relapse rates in alcohol and 
cannabis dependency. 
One strength of this study is the integration of a new developed multi-session ABM 
intervention with face-to-face TAU, given by a trained therapist. On the presumption that 
addiction is maintained by conscious as well as automatic processes, the combination 
of CBT-based intervention with its focus on strengthening decision-making processes 
and conscious reasoning and ABM intervention with its focus on modifying relatively 
automatic processes involved in addiction might well increase treatment outcome and 
reduce rates of relapse. We will embed the ABM intervention into TAU by asking the 
therapists to involve the ABM training in the regular treatment sessions. Therapists 
will motivate the patients to train regularly and according patients will experience 
that both interventions are connected and constitute one treatment program. A second 
strength of this study is that the ABM is a home-delivered internet-based intervention, 
thus allowing patients to train in the same environment where they tend to experience 
high levels of craving. As we have argued, the home of the patients diagnosed with 
substance use disorder might be the best context to deliver these trainings. Home 
delivery will give the patients more freedom and enables them to train when the 
experience of craving is strongest. Furthermore, home-delivered interventions are 
generally less expensive than those that require delivery in the clinic. This makes 
ABM interventions attractive, as they would be relatively inexpensive to implement, 
if proven effective. A third strength of the study is that it will investigate relapse rates 
and long-term effects with two follow-up assessments, at 6 and 12 months after the 
end of TAU and ABM intervention. Gladwin, Wiers and Wiers (2016) have argued that 
follow-up measures may be essential to determine whether treatment innovations 
enhance outcomes in addictions, given that high relapse rates represents the major 
limitation of existing interventions. Because the effects of ABM interventions might 
be especially relevant in situations of stress or other negative circumstances in daily 
life, its benefits may become evident only across the month that follow treatment. 
A final strength of the study is that by gamifying the ABM intervention, we hope to 
improve upon prior approaches to ABM interventions. This more dynamic training 
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mirrors the reality of engaging and disengaging of attention to a greater degree than 
previously used ABM intervention for substance use disorders. In addition, by adding 
game-like features to make the training more appealing, we expect that patients will 
be more inclined to train on a regular basis. 
To sum up, this study will contribute to the knowledge concerning the effectiveness 
of adding a novel ABM intervention to TAU in substance use disorders, by determining 
whether this serves to enhances positive treatment effects and reduces rates of relapse. 
Endnotes
1 In the proposal for the ethical committee attentional bias was listed as secondary 
outcome measure. However, based on current knowledge attentional bias rather serves 
as a manipulation check for the primary outcome measures (clinical effects).
2  The cost-effectiveness analysis was listed as a primary outcome measure in the 
proposal for the ethical committee. However, this analysis only reveals insightful 
results when the treatment will be found to be effective. Therefore, we here consider 
cost-effectiveness as a secondary outcome measure.
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